LMG Life Sciences Awards EMEA 2023 shortlist revealed

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023 shortlist revealed

LMG-LS-2023-EMEA-logo-article

The LMG Life Sciences Awards is excited to announce its shortlist for the 2023 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.

The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.

Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.

A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.

Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.

All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.

If you have any questions regarding our research process, please contact our editor John Harrison

The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.

Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:

  • Patent Litigation Firm of the Year: Biologics & Biosimilars

    Allen & Overy
    Carpmaels & Ransford
    DORDA
    Herbert Smith Freehills
    Pestalozzi Attorneys at Law
    Powell Gilbert
    Taylor Wessing
  • Patent Strategy & Management Firm of the Year

    Bird & Bird
    Deris Attorney at Law Partnership
    Dimitrov Petrov & Co
    Greenberg Traurig
    Kiortsis & Associates
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigator of the Year: Biologics & Biosimilars

    Andreas Seling
    DORDA
    Andri Hess
    Homburger
    David Wilson
    Carpmaels & Ransford
    Emre Kerim Yardimci
    Deris Attorney at Law Partnership
    Laura Orlando
    Herbert Smith Freehills
    Patricia Cappuyns
    Taylor Wessing
    Zoe Butler
    Powell Gilbert

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.



more from across site and ros bottom lb

More from across our site

Sources say they have found the social media platform Bluesky to be a good place to post IP content, while others plan to watch the site closely
The USPTO’s internal ban on AI use, a major SEP ruling rejecting an interim licence request, and the EUIPO’s five-year plan were among the biggest talking points
Speaking to Managing IP, Kathi Vidal says she’s looking forward to helping clients shape policy when she returns to Winston & Strawn
AA Thornton and Venner Shipley’s combination creates a new kid on the block, but one which could rival the major UPC players
Amit Aswal explains why you should take on challenges early in your career and why the IP community is a strong, trustworthy network
Five members of Qantm’s leadership team, including its new managing director, discuss how the business is operating under private equity ownership and reveal expansion plans
In our latest UPC update, we examine an important decision concerning the withdrawal of opt-outs, a significant victory for Edwards, and the launch of a new Hamburg-based IP firm
The combined firm, which will operate under the Venner Shipley name and have 46 partners, will go live in December
Vidal, who recently announced her departure from the USPTO, said she decided to rejoin the firm because of its team and culture
Osborne Clarke said John Linneker’s experience, including acting for SkyKick in the seminal dispute with Sky, will be a huge asset to the firm
Gift this article